[
  {
    "title": "奥精医疗(688613.SH)：BioVeda减持期过半未减持",
    "href": "http://stock.jrj.com.cn/2023/01/05153637261174.shtml",
    "datetime": "2023-01-05 15:36:29",
    "code": "688613"
  },
  {
    "title": "奥精医疗：嘉兴华控拟减持不超过3%股份",
    "href": "http://stock.jrj.com.cn/2022/12/15154037215020.shtml",
    "datetime": "2022-12-15 15:40:06",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：嘉兴华控拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2022/12/15153837215005.shtml",
    "datetime": "2022-12-15 15:38:18",
    "code": "688613"
  },
  {
    "title": "奥精医疗股东嘉兴华控减持487.82万股 套现1.35亿 2022年前三季度公司净利6507.89万",
    "href": "http://stock.jrj.com.cn/2022/12/14195037212976.shtml",
    "datetime": "2022-12-14 19:50:51",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：嘉兴华控已累计减持3.6587%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/14154737211916.shtml",
    "datetime": "2022-12-14 15:47:16",
    "code": "688613"
  },
  {
    "title": "A股异动 | 奥精医疗(688613.SH)跌逾5% 奇伦天佑拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2022/11/09145637123819.shtml",
    "datetime": "2022-11-09 14:56:27",
    "code": "688613"
  },
  {
    "title": "奥精医疗：奇伦天佑拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2022/11/08155037120336.shtml",
    "datetime": "2022-11-08 15:50:27",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：嘉兴华控已合计减持1.28%的股份",
    "href": "http://stock.jrj.com.cn/2022/11/08154637120328.shtml",
    "datetime": "2022-11-08 15:46:38",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：奇伦天佑拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2022/11/08153937120249.shtml",
    "datetime": "2022-11-08 15:39:03",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：嘉兴华控持股比例从8.73%减至7.63%",
    "href": "http://stock.jrj.com.cn/2022/11/03163637109844.shtml",
    "datetime": "2022-11-03 16:36:42",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：股东BioVeda拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2022/10/30212637097897.shtml",
    "datetime": "2022-10-30 21:26:38",
    "code": "688613"
  },
  {
    "title": "奥精医疗2022年前三季度净利6507.89万同比下滑23.45% 每盒产品单位成本增加",
    "href": "http://stock.jrj.com.cn/2022/10/25211137083289.shtml",
    "datetime": "2022-10-25 21:11:35",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)第三季度净利润3224.81万元、同比下降14.52%",
    "href": "http://stock.jrj.com.cn/2022/10/25154937081579.shtml",
    "datetime": "2022-10-25 15:49:52",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：嘉兴华控减持期过半 累计减持0.64%股份",
    "href": "http://stock.jrj.com.cn/2022/09/14154236994072.shtml",
    "datetime": "2022-09-14 15:42:45",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：减持期届满 BioVeda累计减持2.4928%股份",
    "href": "http://stock.jrj.com.cn/2022/09/13153636991143.shtml",
    "datetime": "2022-09-13 15:36:48",
    "code": "688613"
  },
  {
    "title": "前财务负责人、董秘申请劳动仲裁，奥精医疗被要求支付4546万元",
    "href": "http://stock.jrj.com.cn/2022/09/07171936980538.shtml",
    "datetime": "2022-09-07 17:19:16",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：同创成长完成减持0.9975%股份",
    "href": "http://stock.jrj.com.cn/2022/09/01124436962343.shtml",
    "datetime": "2022-09-01 12:44:21",
    "code": "688613"
  },
  {
    "title": "奥精医疗披露2022年半年报 实现营收1.04亿元",
    "href": "http://stock.jrj.com.cn/2022/08/30092536950955.shtml",
    "datetime": "2022-08-30 09:25:42",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613)：持股5%以上股东减持比例超过1%",
    "href": "http://stock.jrj.com.cn/2022/08/24085936928932.shtml",
    "datetime": "2022-08-24 08:59:50",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：奇伦天佑减持股份比例达1.05%",
    "href": "http://stock.jrj.com.cn/2022/08/23154236926220.shtml",
    "datetime": "2022-08-23 15:42:32",
    "code": "688613"
  },
  {
    "title": "奥精医疗（688613）：于苏州国际博览中心举行投资者关系活动",
    "href": "http://stock.jrj.com.cn/2022/08/17091036906663.shtml",
    "datetime": "2022-08-17 09:10:10",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：BioVeda已减持1.2996%的股份",
    "href": "http://stock.jrj.com.cn/2022/08/11211236892211.shtml",
    "datetime": "2022-08-11 21:12:31",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：奇伦天佑持股比例从9.07%减至7.85%",
    "href": "http://stock.jrj.com.cn/2022/08/03165636867060.shtml",
    "datetime": "2022-08-03 16:56:23",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：减持期过半 同创成长累计减持66万股",
    "href": "http://stock.jrj.com.cn/2022/08/01153736859117.shtml",
    "datetime": "2022-08-01 15:37:47",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613)：2021年年度权益分派实施，每10股派发现金红利2.72元（含税）",
    "href": "http://stock.jrj.com.cn/2022/07/08093936793520.shtml",
    "datetime": "2022-07-08 09:39:07",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613)：2021年年度权益分派实施，每10股派发现金红利2.72元",
    "href": "http://stock.jrj.com.cn/2022/07/08093036793399.shtml",
    "datetime": "2022-07-08 09:30:17",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)2021年度权益分派10派2.72元、股权登记日为7月13日",
    "href": "http://stock.jrj.com.cn/2022/07/07195036792021.shtml",
    "datetime": "2022-07-07 19:50:46",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613)：持股5%以上股东减持比例超过1%",
    "href": "http://stock.jrj.com.cn/2022/07/06090036785884.shtml",
    "datetime": "2022-07-06 09:00:25",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：同创成长减持股份达1.0822%",
    "href": "http://stock.jrj.com.cn/2022/07/06080736785749.shtml",
    "datetime": "2022-07-06 08:07:47",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：股东BioVeda近期累计减持1.19%股份",
    "href": "http://stock.jrj.com.cn/2022/06/30172136771926.shtml",
    "datetime": "2022-06-30 17:21:50",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：同创成长拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2022/06/09171736716257.shtml",
    "datetime": "2022-06-09 17:17:24",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：上海百奥以大宗交易累计减持0.71%的股份",
    "href": "http://stock.jrj.com.cn/2022/06/08153936712321.shtml",
    "datetime": "2022-06-08 15:39:41",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：拟聘任崔孟龙为公司总经理",
    "href": "http://stock.jrj.com.cn/2022/06/02154836700366.shtml",
    "datetime": "2022-06-02 15:48:04",
    "code": "688613"
  },
  {
    "title": "快讯：奥精医疗急速拉升9.42% 主力资金净流入612.43万元(dev)",
    "href": "http://stock.jrj.com.cn/2022/06/01113136696120.shtml",
    "datetime": "2022-06-01 11:31:00",
    "code": "688613"
  },
  {
    "title": "奥精医疗股价跌80%三股东拟套现4亿 研发费增1400万致一季度扣非降47%",
    "href": "http://stock.jrj.com.cn/2022/05/26105436680223.shtml",
    "datetime": "2022-05-26 10:54:15",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：成长一期近期累计减持75.72万股 持股降至5%以下",
    "href": "http://stock.jrj.com.cn/2022/05/24160136674183.shtml",
    "datetime": "2022-05-24 16:01:39",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613)：股东减持股份计划",
    "href": "http://stock.jrj.com.cn/2022/05/23083036668995.shtml",
    "datetime": "2022-05-23 08:30:29",
    "code": "688613"
  },
  {
    "title": "一年限售期满，两家公司股东宣布将减持",
    "href": "http://stock.jrj.com.cn/2022/05/23063136668719.shtml",
    "datetime": "2022-05-23 06:31:30",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：7496.8023万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/05/10162936620626.shtml",
    "datetime": "2022-05-10 16:29:53",
    "code": "688613"
  },
  {
    "title": "奥精医疗披露2022年一季报 实现营收4589.27万元",
    "href": "http://stock.jrj.com.cn/2022/05/05084236565895.shtml",
    "datetime": "2022-05-05 08:42:26",
    "code": "688613"
  },
  {
    "title": "奥精医疗2022年第一季度净利1314.87万同比下滑27.32% 研发费用大幅增加",
    "href": "http://stock.jrj.com.cn/2022/05/03193236546571.shtml",
    "datetime": "2022-05-03 19:32:42",
    "code": "688613"
  },
  {
    "title": "奥精医疗2021年净利1.21亿同比增长35.8% 董事长胡刚薪酬136.09万",
    "href": "http://stock.jrj.com.cn/2022/05/02173236533035.shtml",
    "datetime": "2022-05-02 17:32:47",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：2021年净利润增35.80%至1.21亿元 拟10派2.72元",
    "href": "http://stock.jrj.com.cn/2022/04/27215736486861.shtml",
    "datetime": "2022-04-27 21:57:29",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：一季度净利润降27.32%至1314.87万元",
    "href": "http://stock.jrj.com.cn/2022/04/27215436486863.shtml",
    "datetime": "2022-04-27 21:54:38",
    "code": "688613"
  },
  {
    "title": "奥精医疗2021年净利1.21亿同比增长36.06% 经营实现稳健增长",
    "href": "http://stock.jrj.com.cn/2022/02/25185134465604.shtml",
    "datetime": "2022-02-25 18:51:54",
    "code": "688613"
  },
  {
    "title": "奥精医疗董事会秘书辞职 仇志烨接任 2021年第三季度公司净利3772.72万",
    "href": "http://stock.jrj.com.cn/2022/02/14191034345840.shtml",
    "datetime": "2022-02-14 19:10:56",
    "code": "688613"
  },
  {
    "title": "聚焦3D打印等技术 奥精医疗推动个性化仿生矿化胶原儿童颌面骨修复植入器械应用研究",
    "href": "http://stock.jrj.com.cn/2022/01/25221534214484.shtml",
    "datetime": "2022-01-25 22:15:20",
    "code": "688613"
  },
  {
    "title": "奥精医疗成立十七载：持续加强高科技研发 向高端再生医学领域全面迈进",
    "href": "http://stock.jrj.com.cn/2021/12/22163634047674.shtml",
    "datetime": "2021-12-22 16:36:28",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：122.53万股限售股将于11月22日解禁上市",
    "href": "http://stock.jrj.com.cn/2021/11/15191233855701.shtml",
    "datetime": "2021-11-15 19:12:26",
    "code": "688613"
  },
  {
    "title": "奥精医疗2021年前三季度净利增长近84% 创新产品研发收效显著",
    "href": "http://stock.jrj.com.cn/2021/10/29102033775888.shtml",
    "datetime": "2021-10-29 10:20:07",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：第三季度净利增4.26%至3772.72万元",
    "href": "http://stock.jrj.com.cn/2021/10/28155633769015.shtml",
    "datetime": "2021-10-28 15:56:06",
    "code": "688613"
  },
  {
    "title": "奥精医疗上半年净利润增长超371% 研发投入逐年增长支撑产品创新升级",
    "href": "http://stock.jrj.com.cn/2021/08/31131433360685.shtml",
    "datetime": "2021-08-31 13:14:26",
    "code": "688613"
  },
  {
    "title": "奥精医疗2021年半年度净利4728.48万元 同比净利增加371.76%",
    "href": "http://stock.jrj.com.cn/2021/08/31122933359911.shtml",
    "datetime": "2021-08-31 12:29:38",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)上半年净利升371.76%至4728.48万元",
    "href": "http://stock.jrj.com.cn/2021/08/30155333352275.shtml",
    "datetime": "2021-08-30 15:53:46",
    "code": "688613"
  },
  {
    "title": "奥精医疗总经理李洪景辞职 董事长胡刚代行总经理职责",
    "href": "http://stock.jrj.com.cn/2021/08/20211333289455.shtml",
    "datetime": "2021-08-20 21:13:55",
    "code": "688613"
  },
  {
    "title": "奥精医疗：总经理、董秘李洪景辞职 董事长代行其职",
    "href": "http://stock.jrj.com.cn/2021/08/20174333288137.shtml",
    "datetime": "2021-08-20 17:43:00",
    "code": "688613"
  },
  {
    "title": "奥精医疗2021年上半年预计净利4500万-5000万增长348%-398% 国内市场需求恢复",
    "href": "http://stock.jrj.com.cn/2021/06/30220333023926.shtml",
    "datetime": "2021-06-30 22:03:52",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：上半年净利预增348.97%至398.85%",
    "href": "http://stock.jrj.com.cn/2021/06/30182133022748.shtml",
    "datetime": "2021-06-30 18:21:21",
    "code": "688613"
  },
  {
    "title": "奥精医疗成功登陆科创板市值超百亿 将加速扩张产能提升公司市场占有率",
    "href": "http://stock.jrj.com.cn/2021/05/21151632793458.shtml",
    "datetime": "2021-05-21 15:16:59",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：公司股票5月21日起上市交易",
    "href": "http://stock.jrj.com.cn/2021/05/19190532782860.shtml",
    "datetime": "2021-05-19 19:05:26",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)披露上市发行结果：",
    "href": "http://stock.jrj.com.cn/2021/05/17111132768262.shtml",
    "datetime": "2021-05-17 11:11:28",
    "code": "688613"
  },
  {
    "title": "【兑奖啦】科创板奥精医疗网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/05/12200032743726.shtml",
    "datetime": "2021-05-12 20:00:58",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：网上发行最终中签率为0.02806245%",
    "href": "http://stock.jrj.com.cn/2021/05/11190632736748.shtml",
    "datetime": "2021-05-11 19:06:33",
    "code": "688613"
  },
  {
    "title": "今日申购：奥精医疗",
    "href": "http://stock.jrj.com.cn/2021/05/11092832733961.shtml",
    "datetime": "2021-05-11 09:28:00",
    "code": "688613"
  },
  {
    "title": "奥精医疗(688613.SH)：网上路演时间5月10日14:00-17:00",
    "href": "http://stock.jrj.com.cn/2021/05/06221532703682.shtml",
    "datetime": "2021-05-06 22:15:27",
    "code": "688613"
  },
  {
    "title": "诺泰生物、三孚新科、奥精医疗、康拓医疗科创板IPO注册生效",
    "href": "http://stock.jrj.com.cn/2021/04/16094632384445.shtml",
    "datetime": "2021-04-16 09:46:00",
    "code": "688613"
  },
  {
    "title": "奥精医疗回复科创板注册环节意见落实函：对赌协议、经销商核查等被关注",
    "href": "http://stock.jrj.com.cn/2021/04/14105032370080.shtml",
    "datetime": "2021-04-14 10:50:41",
    "code": "688613"
  },
  {
    "title": "蓝箭电子、铁建重工、欧林生物、和辉光电、三孚新科、奥精医疗科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2021/03/05092332076242.shtml",
    "datetime": "2021-03-05 09:23:40",
    "code": "688613"
  },
  {
    "title": "奥精医疗上会在即 体外仿生矿化技术平台助力我国原创高端再生医学材料发展",
    "href": "http://stock.jrj.com.cn/2021/01/12211731678537.shtml",
    "datetime": "2021-01-12 21:17:58",
    "code": "688613"
  },
  {
    "title": "\"迷你\"奥精医疗主要产品北京两检不合格 产能利用率低",
    "href": "http://stock.jrj.com.cn/2021/01/12070831673577.shtml",
    "datetime": "2021-01-12 07:08:00",
    "code": "688613"
  },
  {
    "title": "迅捷兴、奥精医疗将于1月13日科创板上会接受审核",
    "href": "http://stock.jrj.com.cn/2021/01/07111431646817.shtml",
    "datetime": "2021-01-07 11:14:34",
    "code": "688613"
  },
  {
    "title": "迅捷兴、奥精医疗1月13日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2021/01/06180131642641.shtml",
    "datetime": "2021-01-06 18:01:00",
    "code": "688613"
  },
  {
    "title": "拟募资7.89亿元主要用于产能转移 奥精医疗科创板IPO第二轮问询已回复 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/11/06181531231651.shtml",
    "datetime": "2020-11-06 18:15:43",
    "code": "688613"
  }
]